Early morphea during treatment with ibrutinib in a patient with chronic lymphocytic leukemia

被引：0
|
作者：
Ozlem Ozbagcivan
Sevgi Akarsu
Ecem Canturk Nazli
Banu Lebe
Emel Fetil
机构：
[1] Dokuz Eylul University,Faculty of Medicine, Department of Dermatology
[2] Dokuz Eylul University,Faculty of Medicine, Department of Pathology
来源：
Annals of Hematology | 2021年 / 100卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：293 / 294
页数：1
相关论文
共 50 条
  • [1] Early morphea during treatment with ibrutinib in a patient with chronic lymphocytic leukemia
    Ozbagcivan, Ozlem
    Akarsu, Sevgi
    Nazli, Ecem Canturk
    Lebe, Banu
    Fetil, Emel
    ANNALS OF HEMATOLOGY, 2021, 100 (01) : 293 - 294
  • [2] EXPERIENCE OF IBRUTINIB THERAPY IN THE TREATMENT OF PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    Kurkina, N. V.
    Repina, E. A.
    Mashnina, N. N.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2017, 62 (01): : 55 - 56
  • [3] Ibrutinib for the treatment of chronic lymphocytic leukemia
    Deodato, Marina
    Frustaci, Anna Maria
    Zamprogna, Giulia
    Cairoli, Roberto
    Montillo, Marco
    Tedeschi, Alessandra
    EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (05) : 273 - 284
  • [4] Ibrutinib for treatment of chronic lymphocytic leukemia
    Vela, Cory M.
    McBride, Ali
    Jaglowski, Samantha M.
    Andritsos, Leslie A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (06) : 367 - 375
  • [5] Ibrutinib for the treatment of chronic lymphocytic leukemia
    Farooqui, Mohammed Z. H.
    Wiestner, Adrian
    EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (11): : 925 - 933
  • [6] Ibrutinib in Treatment of Patients with chronic lymphocytic Leukemia
    Flammiger, A.
    ONKOLOGE, 2015, 21 (08): : 732 - 733
  • [7] Pharmacokinetics of ibrutinib in a patient with chronic lymphocytic leukemia on hemodialysis
    Ohtani, Toyoji
    Tani, Akiko
    Namme, Yuki
    Namme, Rie
    Hirose, Maki
    Shingu, Ikuo
    Kizawa, Yusuke
    Endo, Akira
    Yasu, Takeo
    CLINICAL NEPHROLOGY, 2022, 98 (06) : 301 - 304
  • [8] Cutaneous mucormycosis in a chronic lymphocytic leukemia patient on ibrutinib
    Sittig, Katherine R.
    Laageide, Leah G.
    Akhtar, Zaheer
    Wall, Geoffrey C.
    Kumar, Sudhir C.
    IDCASES, 2021, 24
  • [9] Ibrutinib treatment via alternative administration in a patient with chronic lymphocytic leukemia and dysphagia
    DiSogra, Kristyn Y.
    Tran, Thuy
    Arnall, Justin R.
    Janes, Amanda
    Moore, Donald C.
    Park, Steven, I
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (05) : 1265 - 1269
  • [10] Ibrutinib for Chronic Lymphocytic Leukemia
    Rigolin, Gian Matteo
    Cavazzini, Francesco
    Cuneo, Antonio
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (16): : 1593 - 1593
12345